| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.2M | -34.6% |
| Cost of Revenue | $9.5M | -36.8% |
| Gross Profit | -$300K | +68.9% |
| R&D Expense | $244K | +50.6% |
| SG&A Expense | $8.7M | -18.7% |
| Operating Income | -$10.1M | +19.9% |
| Pre-tax Income | $4.6M | +136.0% |
| Net Income | $4.6M | +136.0% |
| EPS (Basic) | $1.52 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -69.0% |
| Accounts Receivable | $97K | -26.4% |
| Current Assets | $2.2M | -66.0% |
| Total Assets | $25.7M | +137.9% |
| Current Liabilities | $3.7M | -2.1% |
| Total Liabilities | $3.7M | -13.4% |
| Stockholders' Equity | $22.0M | +237.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | +0.0% |
| Capital Expenditures | $13K | +0.0% |
| Investing Cash Flow | -$5.1M | -110.6% |
| Financing Cash Flow | $9.2M | -35.8% |
| Free Cash Flow | -$8.2M | +0.0% |
| +103.2% |
| EPS (Diluted) | $0.33 | +100.7% |